Patents by Inventor Zhaoli Chen

Zhaoli Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230419004
    Abstract: A method, apparatus and device for predicting wall temperature deviation of a high-temperature heating surface tube panel of a boiler. The method comprises: acquiring factor data that affects wall temperature deviation of a high-temperature heating surface tube panel of a boiler; according to the factor data and a boiler structure, establishing a three-dimensional boiler simulation model in CFD software, and in the boiler simulation model, calculating the swirl intensity of a boiler furnace outlet by using a swirl momentum moment formula, and calculating a wall temperature deviation coefficient of the high-temperature heating surface tube panel of the boiler by using a wall temperature deviation coefficient calculation formula; and performing quadratic fitting processing on the swirl intensity and the wall temperature deviation coefficient, so as to obtain a prediction model.
    Type: Application
    Filed: March 14, 2022
    Publication date: December 28, 2023
    Applicant: CHINA SOUTHERN POWER GRID TECHNOLOGY CO., LTD.
    Inventors: Debo LI, Zhihao CHEN, Zhaoli CHEN, Jinghui SONG, Yongxin FENG
  • Patent number: 11024824
    Abstract: The application discloses an organic electroluminescent device. The organic electroluminescent device includes: a substrate; and an organic luminescent layer including an array of pixel points which include a first electrode, and the first electrode of the pixel points laps with a Vss lead. A length of the first electrode lapping with the Vss lead increases from a starting end of the Vss lead toward a terminating end of the Vss lead.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: June 1, 2021
    Assignee: KunShan Go-Visionox Opto-Electronics Co., Ltd.
    Inventors: Zhaoli Chen, Jinfang Zhang
  • Patent number: 10756296
    Abstract: The present application discloses a packaging structure, the packaging structure includes a first substrate, a side of the first substrate including a power supply terminal; a second substrate; a metal extension layer, extending from the power supply terminal to both ends of the first side of the first substrate; and a packaging layer, covering the metal extension layer and fastening the first substrate and the second substrate.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: August 25, 2020
    Assignee: Kunshan Go-Visionox Opto-Electronics Co., Ltd.
    Inventors: Zhaoli Chen, Jinfang Zhang, Lu Zhang
  • Publication number: 20190280240
    Abstract: The application discloses an organic electroluminescent device. The organic electroluminescent device includes: a substrate; and an organic luminescent layer including an array of pixel points which include a first electrode, and the first electrode of the pixel points laps with a Vss lead. A length of the first electrode lapping with the Vss lead increases from a starting end of the Vss lead toward a terminating end of the Vss lead.
    Type: Application
    Filed: May 30, 2019
    Publication date: September 12, 2019
    Applicant: KunShan Go-Visionox Opto-Electronics Co., Ltd.
    Inventors: Zhaoli CHEN, Jinfang ZHANG
  • Patent number: 10359426
    Abstract: The present invention relates to a method for diagnosing lung cancers such as non-small lung cancer in a subject by using isocitrate dehydrogenase 1 as a diagnostic biomarker. The present invention also relates to a method for predicting the prognosis of the lung cancers such as non-small lung cancer in a subject by using isocitrate dehydrogenase 1 as a prognostic biomarker. The present invention further relates to a method of suppressing proliferation of lung tumor cells in a subject, decreasing growth of lung tumor cells in a subject, or improving survival of a subject with lung cancer by using isocitrate dehydrogenase 1 as a therapeutic target.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: July 23, 2019
    Assignee: Cancer Hospital, Chinese Academy of Medical Sciences
    Inventors: Jie He, Fengwei Tan, Zhaoli Chen, Nan Sun
  • Publication number: 20190207143
    Abstract: The present application discloses a packaging structure, the packaging structure includes a first substrate, a side of the first substrate including a power supply terminal; a second substrate; a metal extension layer, extending from the power supply terminal to both ends of the first side of the first substrate; and a packaging layer, covering the metal extension layer and fastening the first substrate and the second substrate.
    Type: Application
    Filed: March 5, 2019
    Publication date: July 4, 2019
    Inventors: Zhaoli CHEN, Jinfang ZHANG, Lu ZHANG
  • Publication number: 20180017563
    Abstract: The present invention relates to a method for diagnosing lung cancers such as non-small lung cancer in a subject by using isocitrate dehydrogenase 1 as a diagnostic biomarker. The present invention also relates to a method for predicting the prognosis of the lung cancers such as non-small lung cancer in a subject by using isocitrate dehydrogenase 1 as a prognostic biomarker. The present invention further relates to a method of suppressing proliferation of lung tumor cells in a subject, decreasing growth of lung tumor cells in a subject, or improving survival of a subject with lung cancer by using isocitrate dehydrogenase 1 as a therapeutic target.
    Type: Application
    Filed: September 28, 2017
    Publication date: January 18, 2018
    Inventors: Jie HE, Fengwei TAN, Zhaoli CHEN, Nan SUN
  • Patent number: 9797904
    Abstract: The present invention relates to a method for diagnosing the lung cancers such as non small lung cancer in a subject by using isocitrate dehydrogenase 1 as a diagnostic biomarker. The present invention also relates to a method for predicting the prognosis of the lung cancers such as non small lung cancer in a subject by using isocitrate dehydrogenase 1 as a prognostic biomarker. The present invention further relates to a method to suppress proliferation of lung tumor cells in a subject, decrease growth of lung tumor cells in a subject, or improve survival of a subject with lung cancer by using isocitrate dehydrogenase 1 as a therapeutic target.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: October 24, 2017
    Assignee: Cancer Hospital, Chinese Academy of Medical Sciences
    Inventors: Jie He, Fengwei Tan, Zhaoli Chen, Nan Sun
  • Publication number: 20150247859
    Abstract: The present invention relates to a method for diagnosing the lung cancers such as non small lung cancer in a subject by using isocitrate dehydrogenase 1 as a diagnostic biomarker. The present invention also relates to a method for predicting the prognosis of the lung cancers such as non small lung cancer in a subject by using isocitrate dehydrogenase 1 as a prognostic biomarker. The present invention further relates to a method to suppress proliferation of lung tumor cells in a subject, decrease growth of lung tumor cells in a subject, or improve survival of a subject with lung cancer by using isocitrate dehydrogenase 1 as a therapeutic target.
    Type: Application
    Filed: September 13, 2012
    Publication date: September 3, 2015
    Inventors: Jie He, Fengwei Tan, Zhaoli Chen, Nan Sun